Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Prostate Cancer

Free Subscription Articles published in Cancer Res Retrieve available abstracts of 178 articles: HTML format Text format

Single Articles

March 2010
1. CHIN AI , Miyahira AK, Covarrubias A, Teague J, et al
   Toll-like Receptor 3-Mediated Suppression of TRAMP Prostate Cancer Shows the Critical Role of Type I Interferons in Tumor Immune Surveillance.
   Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. SUN Y , St Clair DK, Xu Y, Crooks PA, et al
   A NADPH Oxidase-Dependent Redox Signaling Pathway Mediates the Selective Radiosensitization Effect of Parthenolide in Prostate Cancer Cells.
   Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. THIRUKKUMARAN CM , Nodwell MJ, Hirasawa K, Shi ZQ, et al
   Oncolytic Viral Therapy for Prostate Cancer: Efficacy of Reovirus as a Biological Therapeutic.
   Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. BEN SAHRA I , Laurent K, Giuliano S, Larbret F, et al
   Targeting Cancer Cell Metabolism: The Combination of Metformin and 2-Deoxyglucose Induces p53-Dependent Apoptosis in Prostate Cancer Cells.
   Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. ZOUBEIDI A , Zardan A, Wiedmann RM, Locke J, et al
   Hsp27 Promotes Insulin-Like Growth Factor-I Survival Signaling in Prostate Cancer via p90Rsk-Dependent Phosphorylation and Inactivation of BAD.
   Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. KOUTROS S , Schumacher FR, Hayes RB, Ma J, et al
   Pooled Analysis of Phosphatidylinositol 3-Kinase Pathway Variants and Risk of Prostate Cancer.
   Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
7. BISWAS MH , Du C, Zhang C, Straubhaar J, et al
   Protein Kinase D1 Inhibits Cell Proliferation through Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 Secretion in Prostate Cancer.
   Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. TERADA N , Shimizu Y, Kamba T, Inoue T, et al
   Identification of EP4 as a Potential Target for the Treatment of Castration-Resistant Prostate Cancer Using a Novel Xenograft Model.
   Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. MOSTAGHEL EA , Geng L, Holcomb I, Coleman IM, et al
   Variability in the Androgen Response of Prostate Epithelium to 5{alpha}-Reductase Inhibition: Implications for Prostate Cancer Chemoprevention.
   Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. THOMSEN MK , Ambroisine L, Wynn S, Cheah KS, et al
    SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formation.
    Cancer Res. 2010;70:979-87.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. EDGAR KA , Wallin JJ, Berry M, Lee LB, et al
    Isoform-specific phosphoinositide 3-kinase inhibitors exert distinct effects in solid tumors.
    Cancer Res. 2010;70:1164-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2010
12. MONET M , Lehen'kyi V, Gackiere F, Firlej V, et al
    Role of Cationic Channel TRPV2 in Promoting Prostate Cancer Migration and Progression to Androgen Resistance.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. HOFLAND J , van Weerden WM, Dits NF, Steenbergen J, et al
    Evidence of Limited Contributions for Intratumoral Steroidogenesis in Prostate Cancer.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. HOLTERMAN CE , Franovic A, Payette J, Lee S, et al
    ETS-1 oncogenic activity mediated by transforming growth factor alpha.
    Cancer Res. 2010;70:730-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. WANG J , Ying G, Wang J, Jung Y, et al
    Characterization of Phosphoglycerate Kinase-1 Expression of Stromal Cells Derived from Tumor Microenvironment in Prostate Cancer Progression.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. NARAYANAN R , Yepuru M, Szafran AT, Szwarc M, et al
    Discovery and Mechanistic Characterization of a Novel Selective Nuclear Androgen Receptor Exporter for the Treatment of Prostate Cancer.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. SWIFT SL , Burns JE, Maitland NJ
    Altered expression of neurotensin receptors is associated with the differentiation state of prostate cancer.
    Cancer Res. 2010;70:347-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. ZHANG Y , Ali TZ, Zhou H, D'Souza DR, et al
    ErbB3 binding protein 1 represses metastasis-promoting gene anterior gradient protein 2 in prostate cancer.
    Cancer Res. 2010;70:240-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2009
19. WANG L , Tang H, Thayanithy V, Subramanian S, et al
    Gene Networks and microRNAs Implicated in Aggressive Prostate Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
20. WANG D , Montgomery RB, Schmidt LJ, Mostaghel EA, et al
    Reduced Tumor Necrosis Factor Receptor-Associated Death Domain Expression Is Associated with Prostate Cancer Progression.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. ZHU Y , Stevens RG, Hoffman AE, Fitzgerald LM, et al
    Testing the Circadian Gene Hypothesis in Prostate Cancer: A Population-Based Case-Control Study.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. GU M , Roy S, Raina K, Agarwal C, et al
    Inositol Hexaphosphate Suppresses Growth and Induces Apoptosis in Prostate Carcinoma Cells in Culture and Nude Mouse Xenograft: PI3K-Akt Pathway as Potential Target.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. MULHOLLAND DJ , Xin L, Morim A, Lawson D, et al
    Lin-Sca-1+CD49fhigh Stem/Progenitors Are Tumor-Initiating Cells in the Pten-Null Prostate Cancer Model.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
24. SHAMALADEVI N , Lyn DA, Escudero DO, Lokeshwar BL, et al
    CXC Receptor-1 Silencing Inhibits Androgen-Independent Prostate Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. PENET MF , Pathak AP, Raman V, Ballesteros P, et al
    Noninvasive Multiparametric Imaging of Metastasis-Permissive Microenvironments in a Human Prostate Cancer Xenograft.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. TAMURA K , Makino A, Hullin-Matsuda F, Kobayashi T, et al
    Novel Lipogenic Enzyme ELOVL7 Is Involved in Prostate Cancer Growth through Saturated Long-Chain Fatty Acid Metabolism.
    Cancer Res. 2009;69:8133-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. GAN L , Chen S, Wang Y, Watahiki A, et al
    Inhibition of the Androgen Receptor as a Novel Mechanism of Taxol Chemotherapy in Prostate Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. ALAOUI-JAMALI MA , Bismar TA, Gupta A, Szarek WA, et al
    A Novel Experimental Heme Oxygenase-1-Targeted Therapy for Hormone-Refractory Prostate Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. WALTERING KK , Helenius MA, Sahu B, Manni V, et al
    Increased Expression of Androgen Receptor Sensitizes Prostate Cancer Cells to Low Levels of Androgens.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
30. BASU HS , Thompson TA, Church DR, Clower CC, et al
    A Small Molecule Polyamine Oxidase Inhibitor Blocks Androgen-Induced Oxidative Stress and Delays Prostate Cancer Progression in the Transgenic Adenocarcinoma of the Mouse Prostate Model.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. HOLCOMB IN , Young JM, Coleman IM, Salari K, et al
    Comparative Analyses of Chromosome Alterations in Soft-Tissue Metastases within and across Patients with Castration-Resistant Prostate Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. BALAKUMARAN BS , Porrello A, Hsu DS, Glover W, et al
    MYC Activity Mitigates Response to Rapamycin in Prostate Cancer through Eukaryotic Initiation Factor 4E-Binding Protein 1-Mediated Inhibition of Autophagy.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. PU H , Collazo J, Jones E, Gayheart D, et al
    Dysfunctional transforming growth factor-beta receptor II accelerates prostate tumorigenesis in the TRAMP mouse model.
    Cancer Res. 2009;69:7366-74.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. CAO Q , Gery S, Dashti A, Yin D, et al
    A Role for the Clock Gene Per1 in Prostate Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. ZHANG W , Zhu J, Efferson CL, Ware C, et al
    Inhibition of Tumor Growth Progression by Antiandrogens and mTOR Inhibitor in a Pten-Deficient Mouse Model of Prostate Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. GENUA M , Pandini G, Sisci D, Castoria G, et al
    Role of Cyclic AMP Response Element-Binding Protein in Insulin-like Growth Factor-I Receptor Up-regulation by Sex Steroids in Prostate Cancer Cells.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. PUHR M , Santer FR, Neuwirt H, Susani M, et al
    Down-regulation of Suppressor of Cytokine Signaling-3 Causes Prostate Cancer Cell Death through Activation of the Extrinsic and Intrinsic Apoptosis Pathways.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. RIBAS J , Ni X, Haffner M, Wentzel EA, et al
    miR-21: An Androgen Receptor-Regulated MicroRNA that Promotes Hormone-Dependent and Hormone-Independent Prostate Cancer Growth.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
39. BASANTA D , Strand DW, Lukner RB, Franco OE, et al
    The Role of Transforming Growth Factor-{beta}-Mediated Tumor-Stroma Interactions in Prostate Cancer Progression: An Integrative Approach.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. DASILVA J , Gioeli D, Weber MJ, Parsons SJ, et al
    The Neuroendocrine-Derived Peptide Parathyroid Hormone-Related Protein Promotes Prostate Cancer Cell Growth by Stabilizing the Androgen Receptor.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. KHOR TO , Yu S, Barve A, Hao X, et al
    Dietary Feeding of Dibenzoylmethane Inhibits Prostate Cancer in Transgenic Adenocarcinoma of the Mouse Prostate Model.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. HILLIER SM , Maresca KP, Femia FJ, Marquis JC, et al
    Preclinical Evaluation of Novel Glutamate-Urea-Lysine Analogues That Target Prostate-Specific Membrane Antigen as Molecular Imaging Pharmaceuticals for Prostate Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. ZINGG JM , Azzi A
    Comment Re: Vitamin E Transport Gene Variants and Prostate Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. ATTAR RM , Jure-Kunkel M, Balog A, Cvijic ME, et al
    Discovery of BMS-641988, a Novel and Potent Inhibitor of Androgen Receptor Signaling for the Treatment of Prostate Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. MUDERS MH , Zhang H, Wang E, Tindall DJ, et al
    Vascular endothelial growth factor-C protects prostate cancer cells from oxidative stress by the activation of mammalian target of rapamycin complex-2 and AKT-1.
    Cancer Res. 2009;69:6042-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. SHAFER-WEAVER KA , Watkins SK, Anderson MJ, Draper LJ, et al
    Immunity to murine prostatic tumors: continuous provision of T-cell help prevents CD8 T-cell tolerance and activates tumor-infiltrating dendritic cells.
    Cancer Res. 2009;69:6256-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
47. PANG X , Yi Z, Zhang X, Sung B, et al
    Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis.
    Cancer Res. 2009;69:5893-900.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. CAI C , Wang H, Xu Y, Chen S, et al
    Reactivation of Androgen Receptor-Regulated TMPRSS2:ERG Gene Expression in Castration-Resistant Prostate Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. GOEL HL , Moro L, Murphy-Ullrich JE, Hsieh CC, et al
    Beta1 integrin cytoplasmic variants differentially regulate expression of the antiangiogenic extracellular matrix protein thrombospondin 1.
    Cancer Res. 2009;69:5374-82.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. LIPPMAN SM , Hawk ET
    Cancer prevention: from 1727 to milestones of the past 100 years.
    Cancer Res. 2009;69:5269-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
51. DI VIZIO D , Kim J, Hager MH, Morello M, et al
    Oncosome Formation in Prostate Cancer: Association with a Region of Frequent Chromosomal Deletion in Metastatic Disease.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. POMERANTZ MM , Beckwith CA, Regan MM, Wyman SK, et al
    Evaluation of the 8q24 Prostate Cancer Risk Locus and MYC Expression.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. PORTS MO , Nagle RB, Pond GD, Cress AE, et al
    Extracellular engagement of alpha6 integrin inhibited urokinase-type plasminogen activator-mediated cleavage and delayed human prostate bone metastasis.
    Cancer Res. 2009;69:5007-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. ATTARD G , Reid AH, Olmos D, de Bono JS, et al
    Antitumor Activity with CYP17 Blockade Indicates That Castration-Resistant Prostate Cancer Frequently Remains Hormone Driven.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. CAI C , Portnoy DC, Wang H, Jiang X, et al
    Androgen Receptor Expression in Prostate Cancer Cells Is Suppressed by Activation of Epidermal Growth Factor Receptor and ErbB2.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. GRAVDAL K , Halvorsen OJ, Haukaas SA, Akslen LA, et al
    Proliferation of immature tumor vessels is a novel marker of clinical progression in prostate cancer.
    Cancer Res. 2009;69:4708-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
57. BAILEY CL , Kelly P, Casey PJ
    Activation of Rap1 Promotes Prostate Cancer Metastasis.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. VAVERE AL , Biddlecombe GB, Spees WM, Garbow JR, et al
    A novel technology for the imaging of acidic prostate tumors by positron emission tomography.
    Cancer Res. 2009;69:4510-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. WADA S , Yoshimura K, Hipkiss EL, Harris TJ, et al
    Cyclophosphamide Augments Antitumor Immunity: Studies in an Autochthonous Prostate Cancer Model.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. RAHMAN KW , Banerjee S, Ali S, Ahmad A, et al
    3,3'-Diindolylmethane Enhances Taxotere-Induced Apoptosis in Hormone-Refractory Prostate Cancer Cells through Survivin Down-regulation.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. GRAFF JR , Konicek BW, Lynch RL, Dumstorf CA, et al
    eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival.
    Cancer Res. 2009;69:3866-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. RAINA K , Serkova NJ, Agarwal R
    Silibinin feeding alters the metabolic profile in TRAMP prostatic tumors: 1H-NMRS-based metabolomics study.
    Cancer Res. 2009;69:3731-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
63. RAHRMANN EP , Collier LS, Knutson TP, Doyal ME, et al
    Identification of PDE4D as a Proliferation Promoting Factor in Prostate Cancer Using a Sleeping Beauty Transposon-Based Somatic Mutagenesis Screen.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. WATTERS JL , Gail MH, Weinstein SJ, Virtamo J, et al
    Associations between {alpha}-Tocopherol, {beta}-Carotene, and Retinol and Prostate Cancer Survival.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. MAKOVITZKI A , Fink A, Shai Y
    Suppression of human solid tumor growth in mice by intratumor and systemic inoculation of histidine-rich and pH-dependent host defense-like lytic peptides.
    Cancer Res. 2009;69:3458-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. HU L , Ibrahim S, Liu C, Skaar J, et al
    Thrombin induces tumor cell cycle activation and spontaneous growth by down-regulation of p27Kip1, in association with the up-regulation of Skp2 and MiR-222.
    Cancer Res. 2009;69:3374-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. STEINKAMP MP , O'Mahony OA, Brogley M, Rehman H, et al
    Treatment-Dependent Androgen Receptor Mutations in Prostate Cancer Exploit Multiple Mechanisms to Evade Therapy.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. EL TOUNY LH , Banerjee PP
    Identification of a Biphasic Role for Genistein in the Regulation of Prostate Cancer Growth and Metastasis.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. LI Y , Wang L, Zhang M, Melamed J, et al
    LEF1 in Androgen-Independent Prostate Cancer: Regulation of Androgen Receptor Expression, Prostate Cancer Growth, and Invasion.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. WANG G , Haile S, Comuzzi B, Tien AH, et al
    Osteoblast-Derived Factors Induce an Expression Signature that Identifies Prostate Cancer Metastasis and Hormonal Progression.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. WU K , Katiyar S, Witkiewicz A, Li A, et al
    The Cell Fate Determination Factor Dachshund Inhibits Androgen Receptor Signaling and Prostate Cancer Cellular Growth.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. SUN T , Wang Q, Balk S, Brown M, et al
    The Role of microRNA-221 and microRNA-222 in Androgen-Independent Prostate Cancer Cell Lines.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. XU Y , Josson S, Fang F, Oberley TD, et al
    RelB Enhances Prostate Cancer Growth: Implications for the Role of the Nuclear Factor-{kappa}B Alternative Pathway in Tumorigenicity.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. ATTARD G , Swennenhuis JF, Olmos D, Reid AH, et al
    Characterization of ERG, AR and PTEN Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer.
    Cancer Res. 2009;69:2912-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. SHIOTA M , Izumi H, Tanimoto A, Takahashi M, et al
    Programmed cell death protein 4 down-regulates Y-box binding protein-1 expression via a direct interaction with Twist1 to suppress cancer cell growth.
    Cancer Res. 2009;69:3148-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
76. BOMMAREDDY A , Hahm ER, Xiao D, Powolny AA, et al
    Atg5 Regulates Phenethyl Isothiocyanate-Induced Autophagic and Apoptotic Cell Death in Human Prostate Cancer Cells.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. HSU FC , Sun J, Wiklund F, Isaacs SD, et al
    A Novel Prostate Cancer Susceptibility Locus at 19q13.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. ZOU JX , Guo L, Revenko AS, Tepper CG, et al
    Androgen-Induced Coactivator ANCCA Mediates Specific Androgen Receptor Signaling in Prostate Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. NWACHUKWU JC , Mita P, Ruoff R, Ha S, et al
    Genome-Wide Impact of Androgen Receptor Trapped clone-27 Loss on Androgen-Regulated Transcription in Prostate Cancer Cells.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. PIGNON JC , Koopmansch B, Nolens G, Delacroix L, et al
    Androgen Receptor Controls EGFR and ERBB2 Gene Expression at Different Levels in Prostate Cancer Cell Lines.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. FACOMPRE N , El-Bayoumy K
    Potential Stages for Prostate Cancer Prevention with Selenium: Implications for Cancer Survivors.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. RICKMAN DS , Pflueger D, Moss B, Vandoren VE, et al
    SLC45A3-ELK4 Is a Novel and Frequent Erythroblast Transformation-Specific Fusion Transcript in Prostate Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
83. ROBEY IF , Baggett BK, Kirkpatrick ND, Roe DJ, et al
    Bicarbonate increases tumor pH and inhibits spontaneous metastases.
    Cancer Res. 2009;69:2260-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. CHEN RQ , Yang QK, Lu BW, Yi W, et al
    CDC25B mediates rapamycin-induced oncogenic responses in cancer cells.
    Cancer Res. 2009;69:2663-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. YANG J , Wahdan-Alaswad R, Danielpour D
    Critical role of Smad2 in tumor suppression and transforming growth factor-beta-induced apoptosis of prostate epithelial cells.
    Cancer Res. 2009;69:2185-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
86. MUKHOPADHYAY NK , Kim J, Cinar B, Ramachandran A, et al
    Heterogeneous nuclear ribonucleoprotein K is a novel regulator of androgen receptor translation.
    Cancer Res. 2009;69:2210-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
87. MUHLBRADT E , Asatiani E, Ortner E, Wang A, et al
    NKX3.1 activates expression of insulin-like growth factor binding protein-3 to mediate insulin-like growth factor-I signaling and cell proliferation.
    Cancer Res. 2009;69:2615-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
88. GANDELLINI P , Folini M, Longoni N, Pennati M, et al
    miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon.
    Cancer Res. 2009;69:2287-95.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. WEI Q , Galbenus R, Raza A, Cerny RL, et al
    Androgen-stimulated UDP-glucose dehydrogenase expression limits prostate androgen availability without impacting hyaluronan levels.
    Cancer Res. 2009;69:2332-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. ZHENG C , Ren Z, Wang H, Zhang W, et al
    E2F1 Induces Tumor Cell Survival via Nuclear Factor-{kappa}B-Dependent Induction of EGR1 Transcription in Prostate Cancer Cells.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. LIU W , Sun J, Li G, Zhu Y, et al
    Association of a Germ-Line Copy Number Variation at 2p24.3 and Risk for Aggressive Prostate Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
92. PRITCHARD C , Mecham B, Dumpit R, Coleman I, et al
    Conserved gene expression programs integrate mammalian prostate development and tumorigenesis.
    Cancer Res. 2009;69:1739-47.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. ARORA S , Wang XI, Keenan SM, Andaya C, et al
    Novel microtubule polymerization inhibitor with potent antiproliferative and antitumor activity.
    Cancer Res. 2009;69:1910-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
94. SINGH SV , Warin R, Xiao D, Powolny AA, et al
    Sulforaphane inhibits prostate carcinogenesis and pulmonary metastasis in TRAMP mice in association with increased cytotoxicity of natural killer cells.
    Cancer Res. 2009;69:2117-25.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
95. JAMES MA , Lu Y, Liu Y, Vikis HG, et al
    RGS17, an Overexpressed Gene in Human Lung and Prostate Cancer, Induces Tumor Cell Proliferation Through the Cyclic AMP-PKA-CREB Pathway.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
96. GUO Z , Yang X, Sun F, Jiang R, et al
    A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
97. KOUTROS S , Berndt SI, Sinha R, Ma X, et al
    Xenobiotic Metabolizing Gene Variants, Dietary Heterocyclic Amine Intake, and Risk of Prostate Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
98. GOPALAN A , Leversha MA, Satagopan JM, Zhou Q, et al
    TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy.
    Cancer Res. 2009;69:1400-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
99. JORDAN VC
    A Century of Deciphering the Control Mechanisms of Sex Steroid Action in Breast and Prostate Cancer: The Origins of Targeted Therapy and Chemoprevention.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
100. STOLZENBERG-SOLOMON RZ , Hayes RB, Horst RL, Anderson KE, et al
     Serum Vitamin D and Risk of Pancreatic Cancer in the Prostate, Lung, Colorectal, and Ovarian Screening Trial.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
101. RAMACHANDRAN K , Gopisetty G, Gordian E, Navarro L, et al
     Methylation-Mediated Repression of GADD45{alpha} in Prostate Cancer and Its Role as a Potential Therapeutic Target.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
102. WRIGHT ME , Peters U, Gunter MJ, Moore SC, et al
     Association of Variants in Two Vitamin E Transport Genes with Circulating Vitamin E Concentrations and Prostate Cancer Risk.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
103. KIM DK , Yang JS, Maiti K, Hwang JI, et al
     A Gonadotropin-Releasing Hormone-II Antagonist Induces Autophagy of Prostate Cancer Cells.
     Cancer Res. 2009;69:923-31.
     PubMed     Text format     Related articles    Abstract available
     
     
     
104. WELSBIE DS , Xu J, Chen Y, Borsu L, et al
     Histone Deacetylases Are Required for Androgen Receptor Function in Hormone-Sensitive and Castrate-Resistant Prostate Cancer.
     Cancer Res. 2009;69:958-966.
     PubMed     Text format     Related articles    Abstract available
     
     
     
105. CAI Y , Wang J, Li R, Ayala G, et al
     GGAP2/PIKE-A Directly Activates Both the Akt and Nuclear Factor-{kappa}B Pathways and Promotes Prostate Cancer Progression.
     Cancer Res. 2009;69:819-827.
     PubMed     Text format     Related articles    Abstract available
     
     
     
106. ROY S , Gu M, Ramasamy K, Singh RP, et al
     p21/Cip1 and p27/Kip1 Are Essential Molecular Targets of Inositol Hexaphosphate for Its Antitumor Efficacy against Prostate Cancer.
     Cancer Res. 2009;69:1166-73.
     PubMed     Text format     Related articles    Abstract available
     
     
     
107. CASTELLANA D , Zobairi F, Martinez MC, Panaro MA, et al
     Membrane microvesicles as actors in the establishment of a favorable prostatic tumoral niche: a role for activated fibroblasts and CX3CL1-CX3CR1 axis.
     Cancer Res. 2009;69:785-93.
     PubMed     Text format     Related articles    Abstract available
     
     
     
108. CHUNG I , Han G, Seshadri M, Gillard BM, et al
     Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo.
     Cancer Res. 2009;69:967-75.
     PubMed     Text format     Related articles    Abstract available
     
     
     January 2009
109. LI X , Loberg R, Liao J, Ying C, et al
     A Destructive Cascade Mediated by CCL2 Facilitates Prostate Cancer Growth in Bone.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
110. JIN C , Yang YA, Anver MR, Morris N, et al
     Smad Ubiquitination Regulatory Factor 2 Promotes Metastasis of Breast Cancer Cells by Enhancing Migration and Invasiveness.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
111. SCHARER CD , McCabe CD, Ali-Seyed M, Berger MF, et al
     Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cells.
     Cancer Res. 2009;69:709-17.
     PubMed     Text format     Related articles    Abstract available
     
     
     
112. KIM RH , Coates JM, Bowles TL, McNerney GP, et al
     Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis.
     Cancer Res. 2009;69:700-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
113. HOFER MD , Kuefer R, Maier C, Herkommer K, et al
     Genome-wide linkage analysis of TMPRSS2-ERG fusion in familial prostate cancer.
     Cancer Res. 2009;69:640-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
114. FONG L , Kwek SS, O'Brien S, Kavanagh B, et al
     Potentiating endogenous antitumor immunity to prostate cancer through combination immunotherapy with CTLA4 blockade and GM-CSF.
     Cancer Res. 2009;69:609-15.
     PubMed     Text format     Related articles    Abstract available
     
     
     
115. PANG X , Yi T, Yi Z, Cho SG, et al
     Morelloflavone, a biflavonoid, inhibits tumor angiogenesis by targeting rho GTPases and extracellular signal-regulated kinase signaling pathways.
     Cancer Res. 2009;69:518-25.
     PubMed     Text format     Related articles    Abstract available
     
     
     
116. AYALA I , Giacchetti G, Caldieri G, Attanasio F, et al
     Faciogenital Dysplasia Protein Fgd1 Regulates Invadopodia Biogenesis and Extracellular Matrix Degradation and Is Up-regulated in Prostate and Breast Cancer.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
117. SHIN DS , Kim HN, Shin KD, Yoon YJ, et al
     Cryptotanshinone inhibits constitutive signal transducer and activator of transcription 3 function through blocking the dimerization in DU145 prostate cancer cells.
     Cancer Res. 2009;69:193-202.
     PubMed     Text format     Related articles    Abstract available
     
     
     
118. YANG JC , Ok JH, Busby JE, Borowsky AD, et al
     Aberrant activation of androgen receptor in a new neuropeptide-autocrine model of androgen-insensitive prostate cancer.
     Cancer Res. 2009;69:151-60.
     PubMed     Text format     Related articles    Abstract available
     
     
     
119. TAKAYAMA K , Tsutsumi S, Suzuki T, Horie-Inoue K, et al
     Amyloid precursor protein is a primary androgen target gene that promotes prostate cancer growth.
     Cancer Res. 2009;69:137-42.
     PubMed     Text format     Related articles    Abstract available
     
     
     
120. VILLAR J , Quadri HS, Song I, Tomita Y, et al
     PCPH/ENTPD5 expression confers to prostate cancer cells resistance against cisplatin-induced apoptosis through protein kinase Calpha-mediated Bcl-2 stabilization.
     Cancer Res. 2009;69:102-10.
     PubMed     Text format     Related articles    Abstract available
     
     
     
121. HU R , Dunn TA, Wei S, Isharwal S, et al
     Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer.
     Cancer Res. 2009;69:16-22.
     PubMed     Text format     Related articles    Abstract available
     
     
     
122. SUN J , Zheng SL, Wiklund F, Isaacs SD, et al
     Sequence variants at 22q13 are associated with prostate cancer risk.
     Cancer Res. 2009;69:10-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
123. KARAN D , Holzbeierlein J, Thrasher JB
     Macrophage inhibitory cytokine-1: possible bridge molecule of inflammation and prostate cancer.
     Cancer Res. 2009;69:2-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
124. PEARSON HB , Phesse TJ, Clarke AR
     K-ras and Wnt signaling synergize to accelerate prostate tumorigenesis in the mouse.
     Cancer Res. 2009;69:94-101.
     PubMed     Text format     Related articles    Abstract available
     
     
     December 2008
125. WANG J , Lu Y, Wang J, Koch AE, et al
     CXCR6 induces prostate cancer progression by the AKT/mammalian target of rapamycin signaling pathway.
     Cancer Res. 2008;68:10367-76.
     PubMed     Text format     Related articles    Abstract available
     
     
     
126. LIU P , Li S, Gan L, Kao TP, et al
     A transcription-independent function of FOXO1 in inhibition of androgen-independent activation of the androgen receptor in prostate cancer cells.
     Cancer Res. 2008;68:10290-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
127. COOPER ML , Adami HO, Gronberg H, Wiklund F, et al
     Interaction between single nucleotide polymorphisms in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk.
     Cancer Res. 2008;68:10171-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
128. SHEN H , Powers N, Saini N, Comstock CE, et al
     The SWI/SNF ATPase Brm is a gatekeeper of proliferative control in prostate cancer.
     Cancer Res. 2008;68:10154-62.
     PubMed     Text format     Related articles    Abstract available
     
     
     
129. SUNG SY , Hsieh CL, Law A, Zhau HE, et al
     Coevolution of prostate cancer and bone stroma in three-dimensional coculture: implications for cancer growth and metastasis.
     Cancer Res. 2008;68:9996-10003.
     PubMed     Text format     Related articles    Abstract available
     
     
     
130. WANG G , Wang J, Sadar MD
     Crosstalk between the Androgen Receptor and {beta}-Catenin in Castrate-Resistant Prostate Cancer.
     Cancer Res. 2008;68:9918-27.
     PubMed     Text format     Related articles    Abstract available
     
     
     
131. DENG X , Liu H, Huang J, Cheng L, et al
     Ionizing Radiation Induces Prostate Cancer Neuroendocrine Differentiation through Interplay of CREB and ATF2: Implications for Disease Progression.
     Cancer Res. 2008;68:9663-70.
     PubMed     Text format     Related articles    Abstract available
     
     
     
132. STANDISH BA , Lee KK, Jin X, Mariampillai A, et al
     Interstitial Doppler optical coherence tomography as a local tumor necrosis predictor in photodynamic therapy of prostatic carcinoma: an in vivo study.
     Cancer Res. 2008;68:9987-95.
     PubMed     Text format     Related articles    Abstract available
     
     
     
133. MENNUNI C , Ugel S, Mori F, Cipriani B, et al
     Preventive vaccination with telomerase controls tumor growth in genetically engineered and carcinogen-induced mouse models of cancer.
     Cancer Res. 2008;68:9865-74.
     PubMed     Text format     Related articles    Abstract available
     
     
     
134. ALEKU M , Schulz P, Keil O, Santel A, et al
     Atu027, a liposomal small interfering RNA formulation targeting protein kinase N3, inhibits cancer progression.
     Cancer Res. 2008;68:9788-98.
     PubMed     Text format     Related articles    Abstract available
     
     
     
135. VANDER GRIEND DJ , Karthaus WL, Dalrymple S, Meeker A, et al
     The Role of CD133 in Normal Human Prostate Stem Cells and Malignant Cancer-Initiating Cells.
     Cancer Res. 2008;68:9703-11.
     PubMed     Text format     Related articles    Abstract available
     
     
     November 2008
136. SINGH SV , Powolny AA, Stan SD, Xiao D, et al
     Garlic constituent diallyl trisulfide prevents development of poorly differentiated prostate cancer and pulmonary metastasis multiplicity in TRAMP mice.
     Cancer Res. 2008;68:9503-11.
     PubMed     Text format     Related articles    Abstract available
     
     
     
137. JOSHI BH , Leland P, Calvo A, Green JE, et al
     Human adrenomedullin up-regulates interleukin-13 receptor alpha2 chain in prostate cancer in vitro and in vivo: a novel approach to sensitize prostate cancer to anticancer therapy.
     Cancer Res. 2008;68:9311-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
138. ARNOLDUSSEN YJ , Lorenzo PI, Pretorius ME, Waehre H, et al
     The mitogen-activated protein kinase phosphatase vaccinia H1-related protein inhibits apoptosis in prostate cancer cells and is overexpressed in prostate cancer.
     Cancer Res. 2008;68:9255-64.
     PubMed     Text format     Related articles    Abstract available
     
     
     
139. AZIZ MH , Dreckschmidt NE, Verma AK
     Plumbagin, a medicinal plant-derived naphthoquinone, is a novel inhibitor of the growth and invasion of hormone-refractory prostate cancer.
     Cancer Res. 2008;68:9024-32.
     PubMed     Text format     Related articles    Abstract available
     
     
     
140. YEGNASUBRAMANIAN S , Haffner MC, Zhang Y, Gurel B, et al
     DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity.
     Cancer Res. 2008;68:8954-67.
     PubMed     Text format     Related articles    Abstract available
     
     
     
141. SONG H , Koessler T, Ahmed S, Ramus SJ, et al
     Association Study of Prostate Cancer Susceptibility Variants with Risks of Invasive Ovarian, Breast, and Colorectal Cancer.
     Cancer Res. 2008;68:8837-8842.
     PubMed     Text format     Related articles    Abstract available
     
     
     
142. ZHANG H , Muders MH, Li J, Rinaldo F, et al
     Loss of NKX3.1 Favors Vascular Endothelial Growth Factor-C Expression in Prostate Cancer.
     Cancer Res. 2008;68:8770-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
143. YAO V , Parwani A, Maier C, Heston WD, et al
     Moderate expression of prostate-specific membrane antigen, a tissue differentiation antigen and folate hydrolase, facilitates prostate carcinogenesis.
     Cancer Res. 2008;68:9070-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     October 2008
144. ALBERS MJ , Bok R, Chen AP, Cunningham CH, et al
     Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading.
     Cancer Res. 2008;68:8607-15.
     PubMed     Text format     Related articles    Abstract available
     
     
     
145. HAFEEZ BB , Siddiqui IA, Asim M, Malik A, et al
     A dietary anthocyanidin delphinidin induces apoptosis of human prostate cancer PC3 cells in vitro and in vivo: involvement of nuclear factor-kappaB signaling.
     Cancer Res. 2008;68:8564-72.
     PubMed     Text format     Related articles    Abstract available
     
     
     
146. KHAN N , Asim M, Afaq F, Abu Zaid M, et al
     A novel dietary flavonoid fisetin inhibits androgen receptor signaling and tumor growth in athymic nude mice.
     Cancer Res. 2008;68:8555-63.
     PubMed     Text format     Related articles    Abstract available
     
     
     
147. WANG J , Cai Y, Yu W, Ren C, et al
     Pleiotropic biological activities of alternatively spliced TMPRSS2/ERG fusion gene transcripts.
     Cancer Res. 2008;68:8516-24.
     PubMed     Text format     Related articles    Abstract available
     
     
     
148. CLARK EL , Coulson A, Dalgliesh C, Rajan P, et al
     The RNA helicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancer.
     Cancer Res. 2008;68:7938-46.
     PubMed     Text format     Related articles    Abstract available
     
     
     
149. LEHMANN BD , Paine MS, Brooks AM, McCubrey JA, et al
     Senescence-associated exosome release from human prostate cancer cells.
     Cancer Res. 2008;68:7864-71.
     PubMed     Text format     Related articles    Abstract available
     
     
     
150. BURTON JB , Priceman SJ, Sung JL, Brakenhielm E, et al
     Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis.
     Cancer Res. 2008;68:7828-37.
     PubMed     Text format     Related articles    Abstract available
     
     
     
151. JAIN S , Chakraborty G, Raja R, Kale S, et al
     Prostaglandin E2 regulates tumor angiogenesis in prostate cancer.
     Cancer Res. 2008;68:7750-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
152. LIU LZ , Zheng JZ, Wang XR, Jiang BH, et al
     Endothelial p70 S6 kinase 1 in regulating tumor angiogenesis.
     Cancer Res. 2008;68:8183-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
153. SONG K , Wang H, Krebs TL, Kim SJ, et al
     Androgenic control of transforming growth factor-beta signaling in prostate epithelial cells through transcriptional suppression of transforming growth factor-beta receptor II.
     Cancer Res. 2008;68:8173-82.
     PubMed     Text format     Related articles    Abstract available
     
     
     
154. QIN HR , Kim HJ, Kim JY, Hurt EM, et al
     Activation of signal transducer and activator of transcription 3 through a phosphomimetic serine 727 promotes prostate tumorigenesis independent of tyrosine 705 phosphorylation.
     Cancer Res. 2008;68:7736-41.
     PubMed     Text format     Related articles    Abstract available
     
     
     
155. LIAO YC , Shih YP, Lo SH
     Mutations in the focal adhesion targeting region of deleted in liver cancer-1 attenuate their expression and function.
     Cancer Res. 2008;68:7718-22.
     PubMed     Text format     Related articles    Abstract available
     
     
     September 2008
156. HAN B , Mehra R, Dhanasekaran SM, Yu J, et al
     A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer.
     Cancer Res. 2008;68:7629-37.
     PubMed     Text format     Related articles    Abstract available
     
     
     
157. IIIZUMI M , Bandyopadhyay S, Pai SK, Watabe M, et al
     RhoC promotes metastasis via activation of the Pyk2 pathway in prostate cancer.
     Cancer Res. 2008;68:7613-20.
     PubMed     Text format     Related articles    Abstract available
     
     
     
158. HERMANS KG , van der Korput HA, van Marion R, van de Wijngaart DJ, et al
     Truncated ETV1, fused to novel tissue-specific genes, and full-length ETV1 in prostate cancer.
     Cancer Res. 2008;68:7541-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
159. SHERK AB , Frigo DE, Schnackenberg CG, Bray JD, et al
     Development of a small-molecule serum- and glucocorticoid-regulated kinase-1 antagonist and its evaluation as a prostate cancer therapeutic.
     Cancer Res. 2008;68:7475-83.
     PubMed     Text format     Related articles    Abstract available
     
     
     
160. KWON M , Hanna E, Lorang D, He M, et al
     Functional characterization of filamin a interacting protein 1-like, a novel candidate for antivascular cancer therapy.
     Cancer Res. 2008;68:7332-41.
     PubMed     Text format     Related articles    Abstract available
     
     
     
161. NIU Y , Yeh S, Miyamoto H, Li G, et al
     Tissue prostate-specific antigen facilitates refractory prostate tumor progression via enhancing ARA70-regulated androgen receptor transactivation.
     Cancer Res. 2008;68:7110-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
162. VENE R , Larghero P, Arena G, Sporn MB, et al
     Glycogen synthase kinase 3beta regulates cell death induced by synthetic triterpenoids.
     Cancer Res. 2008;68:6987-96.
     PubMed     Text format     Related articles    Abstract available
     
     
     August 2008
163. KIM J , Choi YL, Vallentin A, Hunrichs BS, et al
     Centrosomal PKCbetaII and pericentrin are critical for human prostate cancer growth and angiogenesis.
     Cancer Res. 2008;68:6831-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
164. JIN RJ , Lho Y, Connelly L, Wang Y, et al
     The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth.
     Cancer Res. 2008;68:6762-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
165. LEVIN AM , Machiela MJ, Zuhlke KA, Ray AM, et al
     Chromosome 17q12 variants contribute to risk of early-onset prostate cancer.
     Cancer Res. 2008;68:6492-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
166. RAINA K , Rajamanickam S, Singh RP, Deep G, et al
     Stage-specific inhibitory effects and associated mechanisms of silibinin on tumor progression and metastasis in transgenic adenocarcinoma of the mouse prostate model.
     Cancer Res. 2008;68:6822-30.
     PubMed     Text format     Related articles    Abstract available
     
     
     
167. FU VX , Dobosy JR, Desotelle JA, Almassi N, et al
     Aging and cancer-related loss of insulin-like growth factor 2 imprinting in the mouse and human prostate.
     Cancer Res. 2008;68:6797-802.
     PubMed     Text format     Related articles    Abstract available
     
     
     
168. LIN FM , Tsai CH, Yang YC, Tu WC, et al
     A novel diterpene suppresses CWR22Rv1 tumor growth in vivo through antiproliferation and proapoptosis.
     Cancer Res. 2008;68:6634-42.
     PubMed     Text format     Related articles    Abstract available
     
     
     
169. LOCKE JA , Guns ES, Lubik AA, Adomat HH, et al
     Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer.
     Cancer Res. 2008;68:6407-15.
     PubMed     Text format     Related articles    Abstract available
     
     
     
170. LIU Y , Mo JQ, Hu Q, Boivin G, et al
     Targeted overexpression of vav3 oncogene in prostatic epithelium induces nonbacterial prostatitis and prostate cancer.
     Cancer Res. 2008;68:6396-406.
     PubMed     Text format     Related articles    Abstract available
     
     
     
171. AMBS S , Prueitt RL, Yi M, Hudson RS, et al
     Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer.
     Cancer Res. 2008;68:6162-70.
     PubMed     Text format     Related articles    Abstract available
     
     
     
172. DAS S , Hahn Y, Walker DA, Nagata S, et al
     Topology of NGEP, a prostate-specific cell:cell junction protein widely expressed in many cancers of different grade level.
     Cancer Res. 2008;68:6306-12.
     PubMed     Text format     Related articles    Abstract available
     
     
     July 2008
173. YAN J , Erdem H, Li R, Cai Y, et al
     Steroid receptor coactivator-3/AIB1 promotes cell migration and invasiveness through focal adhesion turnover and matrix metalloproteinase expression.
     Cancer Res. 2008;68:5460-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     June 2008
174. ARRACH N , Zhao M, Porwollik S, Hoffman RM, et al
     Salmonella promoters preferentially activated inside tumors.
     Cancer Res. 2008;68:4827-32.
     PubMed     Text format     Related articles    Abstract available
     
     
     
175. SIEMENS DR , Hu N, Sheikhi AK, Chung E, et al
     Hypoxia increases tumor cell shedding of MHC class I chain-related molecule: role of nitric oxide.
     Cancer Res. 2008;68:4746-53.
     PubMed     Text format     Related articles    Abstract available
     
     
     
176. PLACENCIO VR , Sharif-Afshar AR, Li X, Huang H, et al
     Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity.
     Cancer Res. 2008;68:4709-18.
     PubMed     Text format     Related articles    Abstract available
     
     
     
177. MOSSINE VV , Chopra P, Mawhinney TP
     Interaction of tomato lycopene and ketosamine against rat prostate tumorigenesis.
     Cancer Res. 2008;68:4384-91.
     PubMed     Text format     Related articles    Abstract available
     
     
     
178. WANG L , Sloper DT, Addo SN, Tian D, et al
     WL-276, an antagonist against Bcl-2 proteins, overcomes drug resistance and suppresses prostate tumor growth.
     Cancer Res. 2008;68:4377-83.
     PubMed     Text format     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: